Delivery Order SPE2DB25D3005-SPE2DB26FQAWS
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Dexamethasone 10 mg/ml vials with a ceiling value of $1,171.69. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded contract. The work is to be completed by September 18, 2025, and will be performed at the company's corporate office in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Dexamethasone 120 mg/30 ml vials with a ceiling value of $1,050.40. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by August 11, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary...
- The Defense Logistics Agency awarded a $2,466.91 delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Dexamethasone 20 mg/5 mL vials. This firm fixed-price, competitively awarded contract—with no set-aside designation—is scheduled for completion by September 15, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Dexamethasone is a corticosteroid medication commonly used in military and federal healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Dexamethasone 20 mg/5 mL vials with a ceiling value of $2,195.16. This competitively awarded, firm fixed-price contract is non-set-aside and scheduled for completion by October 27, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. Dexamethasone is a corticosteroid medication used across military and federal...
- The Defense Logistics Agency awarded a $2,619.29 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Dexamethasone 10 mg/mL vials. This competitively awarded, firm fixed-price delivery order is set to conclude on August 13, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $3,457.77 firm fixed price delivery order to AmerisourceBergen Drug Corp for Dexamethasone 10 mg/mL vials, with an ultimate completion date of September 30, 2025. This non-set-aside award was made on September 29, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government, specifically...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 5, 2025, for the supply of Dexamethasone 120 mg/30 mL vials. This competitive, non-set-aside contract is structured as a firm fixed-price delivery order with a ceiling value of $2,700.82 and an ultimate completion date of June 6, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Dexamethasone 20 mg/5 ml vials in 5 ml quantities, with a ceiling value of $1,046.46. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 9, 2025. This delivery...
- The Defense Logistics Agency awarded a $3,267.86 firm fixed price delivery order to AmerisourceBergen Drug Corp for Dexamethasone 10 mg/mL vials, with an ultimate completion date of October 27, 2025. This non-set-aside contract was competitively awarded on October 24, 2025, with performance to be executed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Dexamethasone 20 mg/5 mL vials with a ceiling value of $1,343.25. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under an open competition process. The order is scheduled for completion by August 4, 2025, and will be fulfilled from the contractor's operations in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major...
- SPE2DB25D3005Indefinite Delivery Contract
- SPE2DB25D3005-SPE2DB26FQAWSDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Dexamethasone 20 mg/5 ml vials with a ceiling value of $1,066.93. This is a firm fixed-price delivery order with an ultimate completion date of October 31, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. Dexamethasone is a corticosteroid medication commonly used in military and federal healthcare systems for inflammation management and various medical conditions. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen Drug Corp supplies a comprehensive range of pharmaceutical products and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio of federal contracts reflects its established capability to meet competitive procurement requirements for pharmaceutical and medical supply needs across multiple therapeutic domains through the DLA's Medical Supply Chain network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 10/30/25 |